5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement

---

Ozkul Y., Evereklioglu C., Borlu M., Taheri S., Calis M., Dundar M., ...Daha Fazla

BRITISH JOURNAL OF OPHTHALMOLOGY, cilt.89, sa.12, ss.1634-1637, 2005 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 89 Sayı: 12
• Basım Tarihi: 2005
• Doi Numarası: 10.1136/bjo.2005.076836
• Dergi Adı: BRITISH JOURNAL OF OPHTHALMOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.1634-1637
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Erciyes Üniversitesi Adresli: Evet

Özet

Background: Increased serum levels of homocysteine (Hcy) have been reported in patients with Behcet's disease ( BD) with an established risk factor for vascular involvement. Recently, the authors demonstrated that elevated Hcy levels are associated with ocular involvement in such patients. On the other hand, elevated levels of Hcy can result from genetic errors. Indeed, a mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) gene influences Hcy metabolism and, therefore, MTHFR C677T polymorphism provokes hyperhomocysteinaemia.